The American Journal of Surgery
Volume 199, Issue 3 , Pages 315-318 , March 2010

Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer

Received 15 July 2009 ,Revised 9 August 2009

References 

  1. Chen H, Roberts JR, Ball DW, et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg. 1998;227:887–895
  2. Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary thyroid cancer. Oncologist. 2008;13:539–547
  3. Hahm JR, Lee MS, Min YK, et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid. 2001;11:73–80
  4. Moley JF, Lairmore TC, Phay JE. Hereditary endocrinopathies. Curr Probl Surg. 1999;36:653–762
  5. Kebebew E, Kikuchi S, Duh QY, et al. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg. 2000;135:895–901
  6. Chen H, Thiagalingam A, Chopra H, et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HE'S-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A. 1997;94:5355–5360
  7. Sippel RS, Carpenter JE, Kunnimalaiyaan M, et al. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery. 2003;134:866–871
  8. Borges M, Linnoila RI, van de Velde HJ, et al. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature. 1997;386:852–855
  9. Chen H, Biel MA, Borges MW, et al. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. Cell Growth Differ. 1997;8:677–686
  10. Lanigan TM, DeRaad SK, Russo AF. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells. J Neurobiol. 1998;34:126–134
  11. Dhillon AS, Hagan S, Rath O, et al. Map kinase signalling pathways in cancer. Oncogene. 2007;26:3279–3290
  12. Vaccaro A, Chen H, Kunnimalaiyaan M. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer. Anticancer Drugs. 2006;17:849–853
  13. Dell‘Eva R, Ambrosini C, Vannini N, et al. AKT/NF-κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer. 2007;110:2007–2011
  14. Delmulle L, Bellahcene A, Dhooge W, et al. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine. 2006;13:732–734
  15. Ho YC, Liu CH, Chen CN, et al. Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother Res. 2008;22:1465–1468
  16. Koo JH, Kim HT, Yoon HY, et al. Effect of xanthohumol on melanogenesis in B16 melanoma cells. Exp Mol Med. 2008;40:313–319
  17. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, et al. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem. 2006;281:39819–39830
  18. Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, et al. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist. 2007;12:942–951
  19. Chen H, Kunnimalaiyaan M, Van Gompel JJ. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1. Thyroidology. 2005;15:511–521
  20. Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg. 1999;33:1–27

 Supported by the Howard Hughes Medical Research Institute (M.R.C.), NIH−R 21 CA117117 (H.C.), NIH−R01 CA109053 (H.C.), NIH–RO1 CA121115 (H.C.), American College of Surgeons, George H.A. Clowes Jr Memorial Research Career Development Award (H.C.), and Carcinoid Cancer Foundation Research Award (H.C.).

PII: S0002-9610(09)00756-9

doi: 10.1016/j.amjsurg.2009.08.034

The American Journal of Surgery
Volume 199, Issue 3 , Pages 315-318 , March 2010